2013
DOI: 10.1128/aac.01945-12
|View full text |Cite
|
Sign up to set email alerts
|

NVC-422 Inactivates Staphylococcus aureus Toxins

Abstract: Bacterial pathogens have specific virulence factors (e.g., toxins) that contribute significantly to the virulence and infectivity of microorganisms within the human hosts. Virulence factors are molecules expressed by pathogens that enable colonization, immunoevasion, and immunosuppression, obtaining nutrients from the host or gaining entry into host cells. They can cause pathogenesis by inhibiting or stimulating certain host functions. For example, in systemic Staphylococcus aureus infections, virulence factor… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
12
0

Year Published

2014
2014
2023
2023

Publication Types

Select...
7
1

Relationship

3
5

Authors

Journals

citations
Cited by 11 publications
(12 citation statements)
references
References 18 publications
0
12
0
Order By: Relevance
“…TSST-1 is a superantigen that stimulates the release of large amounts of proinflammatory factors in human infection, has been associated with human toxic shock syndrome [55], and causes sepsis by uncontrolled stimulation of T lymphocytes triggering a cytokine storm [56]. TSST-1 element is carried on a pathogenicity island known now as Sapl1, carrying the tst and other virulence factors [57].…”
Section: Discussionmentioning
confidence: 99%
“…TSST-1 is a superantigen that stimulates the release of large amounts of proinflammatory factors in human infection, has been associated with human toxic shock syndrome [55], and causes sepsis by uncontrolled stimulation of T lymphocytes triggering a cytokine storm [56]. TSST-1 element is carried on a pathogenicity island known now as Sapl1, carrying the tst and other virulence factors [57].…”
Section: Discussionmentioning
confidence: 99%
“…Adherence of bacteria to surfaces is mediated by proteins in S. aureus (16), S. epidermidis (2), and P. aeruginosa (17). Since NCT and analog substances recently have been shown to directly inactivate bacterial toxins (8,18), it seems likely that the detachment of biofilms by NCT is due to an impact on these adherence proteins via oxidation of thiols and aromatic and amino groups (4,5). To clarify the exact molecular sites of attack could be an interesting item in future studies.…”
Section: Discussionmentioning
confidence: 99%
“…Auriclosene (28) was designed to be a more stable derivative of the naturally occurring oxidant N-dichlorotaurine [172][173][174][175] and also was recently shown to inactivate S. aureus toxins. 176 Lefamulin (29) (BC-3781) is a semi-synthetic pleuromutilin 177,178 derivative originally discovered by Nabriva Therapeutics AG (Vienna, Austria). Nabriva executed an Initial Public Offering of shares in September 2015, raising $92 m to progress lefamulin (29) into phase-III trials for CABP.…”
Section: Compounds Undergoing Clinical Evaluationmentioning
confidence: 99%